MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats

Folia Histochemica et Cytobiologica

Volumn 48, Issue 3, 2010, Pages 455-461

  Fan, Jun ^a   Li, Xiang ^a   Zhong, Linlin ^b   Hao Tong, ^a   Di, Jing ^a   Liu, Fang ^a   Zhao, Hai Hua ^a   Bai, Shu Ling ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion molecules; Ascending aortic aneurysm; Inflammation; MMP; Rat

Indexed keywords

GELATINASE A; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ANEURYSM; ARTERY DILATATION; ARTICLE; ASCENDING AORTA; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MICROSCOPY; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SCANNING ELECTRON MICROSCOPY; ZYMOGRAPHY;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 78649582380     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-010-0042-y     Document Type: Article

References (42)

1. Bickerstaff LK, Pairolero PC, Hollier LH, Melton LJ, Van Peenen HJ, Cherry KJ et al., Thoracic aortic aneurysms: a population-based study. Surgery. 1982;92;1103-1108.
2. Jones JA, Spinale FG, Ikonomidis JS. Transforming growth factor-beta signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J Vasc Res. 2009;46:119-137.
3. Tang PC, Yakimov AO, Teesdale MA, Coady MA, Dardik A, Elefteriades JA et al. Transmural inflammation by interferongamma- producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms. FASEB J. 2005;19:1528-1530.
4. He R, Guo DC, Estrera AL, Safi HJ, Huynh TT, Yin Z et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg. 2006; 131:671-678.
5. He R, Guo DC, Sun W, Papke CL, Duraisamy S, Estrera AL et al., Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J Thorac Cardiovasc Surg. 2008;136:922-929.
6. Gong Y, Hart E, Shchurin A, Hoover-Plow J. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J Clin Invest. 2008;118:3012-3024.
7. Brophy CM, Reilly JM, Smith GJ, Tilson MD. The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg. 1991;5:229-233.
8. Milioti N, Bermudez-Fajardo A, Penichet ML, Oviedo-Orta E. Antigen-induced immunomodulation in the pathogenesis of atherosclerosis. Clin Dev Immunol. 2008;2008:723539.
9. Collier IE, Smith J, Kronberger A, Bauer EA, Wilhelm SM, Eisen AZ et al. The structure of the human skin fibroblast collagenase gene. J Biol Chem. 1988;263:10711-10713.
10. Xu QB, Oberhuber G, Gruschwitz M, Wick G. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin Immunol Immunopathol. 1990;56:344-359.
11. Katsuda S, Boyd HC, Fligner C, Ross R, Gown AM. Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol. 1992;140:907-914.
12. Bobryshev YV, Lord RS, S-100 positive cells in human arterial intima and in atherosclerotic lesions. Cardiovasc Res. 1995;29:689-696.
13. Millonig G, Malcom GT, Wick G. Early inflammatoryimmunological lesions in juvenile atherosclerosis from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY)-study. Atherosclerosis. 2002;160:441-448.
14. Ocana E, Perez-Requena J, Bohorquez JC, Brieva JA, Rodriguez C. Chemokine receptor expression on infiltrating lymphocytes from abdominal aortic aneurysms: role of CXCR4-CXCL12 in lymphoid recruitment. Atherosclerosis. 2008;200:264-270.
15. Kaufmann BA, Sanders JM, Davis C, Xie A, Aldred P, Sarembock IJ et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116:276-284.
16. Rollins BJ. Chemokines. Blood. 1997;90:909-928.
17. Fan J, Bai SL, Zhu XB. Expression of matrix metalloproteinase-3, matrix metalloproteinase-9 in the ascending aortic aneurysm. Chin J Histochem Cytochem. 2005a;5:536-539.
18. Fan J, Bai SL, Cao DS., Wang W, Zhu XB. Morphological study on ascending aortic aneurysms induced by ascending aorta banding. Acta Anatomic Sinica. 2005b;36:442-446.
19. Zarins CK, Runyon-Hass A, Zatina MA, Lu CT, Glagov S. Increased collagenase activity in early aneurysmal dilatation. J Vasc Surg. 1986;3:238-248.
20. Longo GM, Xiong W, Greiner TC, Zhao Y, Fiotti N, Baxter BT. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest. 2002;110:625-632.
21. Sadek M, Hynecek RL, Goldenberg S, Kent KC, Marin ML, Faries PL. Gene expression analysis of a porcine native abdominal aortic aneurysm model. Surgery. 2008;144:252-258.
22. Freestone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1995;15:1145-1151.
23. Vainas T, Lubbers T, Stassen FR, Herngreen SB, van Dieijen- Visser MP, Bruggeman CA et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003;107:1103-1105.
24. Weissberg PL, Bennett MR. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340:1928-1929.
25. Keane MG, Wiegers SE, Plappert T, Pochettino A, Bavaria JE, Sutton MG. Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. Circulation. 2000;102:III35-III39.
26. Wilton E, Bland M, Thompson M, Jahangiri M. Matrix metalloproteinase expression in the ascending aorta and aortic valve. Interact Cardiovasc Thorac Surg. 2008; 7:37-40.
27. Ikonomidis JS, Gibson WC, Gardner J, Sweterlitsch S, Thompson RP, Mukherjee R et al.Amurine model of thoracic aortic aneurysms. J Surg Res. 2003;115:157-163.
28. Constans J, Conri C. Circulating markers of endothelial function in cardiovascular disease. Clin Chim Acta. 2006;368:33-47.
29. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res. 2007;101:234-247.
30. Szekanecz, Z., Shah, M.R., Pearce, W.H., Koch, A.E.: Increased intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms. Clin Exp Immunol. 1994; 98:337-343.
31. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke. 2008; 39:1276-1285.
32. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson- Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140:665-673.
33. Fisker Hag AM, Pedersen SF, Kjaer A. Gene expression of LOX-1, VCAM-1, and ICAM-1 in pre-atherosclerotic mice. Biochem Biophys Res Commun. 2008;377: 689-693.
34. Egashira K. Molecular mechanisms mediating inflammation in vascular disease: special reference to monocyte chemoattractant protein-1. Hypertension. 2003;41:834-1841.
35. Linton MF, Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord. 2003;27:Suppl 3:S35-S40.
36. Ishibashi M, Egashira K, Zhao Q, Hiasa K, Ohtani K, Ihara Y et al. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol. 2004;24:174-178.
37. Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006;26:2605-2613.
38. Middleton RK, Bown MJ, Lloyd GM, Jones JL, London NJ, Sayers RD. Characterisation of Interleukin-8 and monocyte chemoattractant protein-1 expression within the abdominal aortic aneurysm and their association with mural inflammation. Eur J Vasc Endovasc Surg. 2009;37:46-55.
39. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N. Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke. 2009;40: 942-951.
40. Chow AK, Cena J, Schulz R. Acute actions and novel targets of matrix metalloproteinases in the heart and vasculature. Br J Pharmacol. 2007;152:189-205.
41. Aoudjit F, Potworowski EF, St-Pierre Y. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J Immunol. 1998;160: 2967-2973.
42. Fang ZY, Lin R, Yuan BX, Liu Y, Zhang H. Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet. Life Sci. 2007;81:1339-1345.